NOV 17, 2020 3:30 PM PST

Antibiotics Before Age 2 Linked to Childhood Health Conditions

WRITTEN BY: Annie Lennon

Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased risk for various conditions, including ADHD, allergies, and obesity. 

For the study, the researchers examined data from over 14,500 children from the Rochester Epidemiology Project. The children were born between January 1st, 2003, and December 31st, 2011. Around 70% had received at least one treatment of antibiotics for illness before the age of two.

In the end, the researchers found that early exposure to antibiotics was linked to a higher risk for a range of conditions. These included childhood-onset asthma, allergic rhinitis, atopic dermatitis, celiac disease, overweightedness, obesity, and ADHD. The development of different disorders seemed to be linked to the number, type, and timing of exposure to antibiotics. Furthermore, they found that children exposed to the drugs were more likely to have a combination of conditions. 

The researchers speculate that the reason for this correlation may be linked to the microbiome, which is particularly sensitive in infants. While the effects of antibiotics may be transient, they say that the drugs may have long-term negative effects on health nevertheless. 

“We want to emphasize that this study shows association ― not causation ― of these conditions,” says Nathan LeBrasseur, Ph.D., senior author if the study. “These findings offer the opportunity to target future research to determine more reliable and safer approaches to timing, dosing, and types of antibiotics for children in this age group.”

The researchers hope their findings will go on to inform guidelines for physicians on the safest way to administer antibiotics early in life. This comes especially given recent increases in the incidence of some of the childhood conditions mentioned in the study- although early antibiotic usage has not been established as direct causation. 

 

Sources: Neuroscience NewsMayo Clinic Proceedings

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 15, 2020
Cannabis Sciences
Can Cannabis Treat Traumatic Brain Injury?
OCT 15, 2020
Can Cannabis Treat Traumatic Brain Injury?
Traumatic brain injury (TBI) happens when the head is violently hit by an object or when an object pierces the skull and ...
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
OCT 18, 2020
Drug Discovery & Development
Virus-Mimicking Drug
OCT 18, 2020
Virus-Mimicking Drug
Scientists have found drug that a drug activates the body’s immune system by behaving like a virus and may make ce ...
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
Loading Comments...